Speaker

Holly Kordasiewicz is the Vice President of Neurology Research at Ionis Pharmaceuticals, a company that specialises in RNA therapeutics. She heads a team focused on the identification of antisense oligonucleotide therapeutics for currently untreatable neurodegenerative diseases, including drugs now in clinical trials for amyotrophic lateral sclerosis, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. Kordasiewicz joined Ionis Pharmaceuticals 8 years ago after working on preclinical validation for Ionis’ Huntington’s disease programme as a postdoctoral fellow in the laboratory of Dr Don Cleveland at the University of California, San Diego. Kordasiewicz began her work on understanding neurodegenerative diseases at the University of Minnesota, where she received her PhD in neuroscience.

« Go Back